What is a stock summary page? Click here for an overview.
Business Description
23andMe Holding Co
NAICS : 621512
SIC : 8734
ISIN : US90138Q1085
Share Class Description:
MEHCQ: Class ADescription
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.31 | |||||
| Equity-to-Asset | 0.23 | |||||
| Debt-to-Equity | 0.97 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -16.38 | |||||
| Beneish M-Score | -3.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.4 | |||||
| 3-Year EBITDA Growth Rate | -14.7 | |||||
| 3-Year EPS without NRI Growth Rate | -21.1 | |||||
| 3-Year FCF Growth Rate | -22.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.17 | |||||
| 9-Day RSI | 60.4 | |||||
| 14-Day RSI | 52.63 | |||||
| 3-1 Month Momentum % | -79.14 | |||||
| 6-1 Month Momentum % | -84.95 | |||||
| 12-1 Month Momentum % | -92.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.05 | |||||
| Quick Ratio | 0.91 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 59.07 | |||||
| Days Sales Outstanding | 11.57 | |||||
| Days Payable | 37.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.4 | |||||
| Shareholder Yield % | 31.88 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.16 | |||||
| Operating Margin % | -140.25 | |||||
| Net Margin % | -186.98 | |||||
| FCF Margin % | -77.72 | |||||
| ROE % | -223.36 | |||||
| ROA % | -99.19 | |||||
| ROIC % | -112.54 | |||||
| 3-Year ROIIC % | -2963.92 | |||||
| ROC (Joel Greenblatt) % | -411.2 | |||||
| ROCE % | -118.33 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.18 | |||||
| PB Ratio | 0.6 | |||||
| Price-to-Tangible-Book | 2.55 | |||||
| EV-to-EBIT | -0.05 | |||||
| EV-to-Forward-EBIT | -0.57 | |||||
| EV-to-EBITDA | -0.06 | |||||
| EV-to-Forward-EBITDA | -0.61 | |||||
| EV-to-Revenue | 0.08 | |||||
| EV-to-Forward-Revenue | 0.76 | |||||
| EV-to-FCF | -0.1 | |||||
| Price-to-GF-Value | 0.08 | |||||
| Earnings Yield (Greenblatt) % | -2000 | |||||
| FCF Yield % | -431.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MEHCQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
23andMe Holding Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 208.775 | ||
| EPS (TTM) ($) | -15.73 | ||
| Beta | 1.53 | ||
| 3-Year Sharpe Ratio | -1.99 | ||
| 3-Year Sortino Ratio | -1.82 | ||
| Volatility % | 75.02 | ||
| 14-Day RSI | 52.63 | ||
| 14-Day ATR ($) | 0.25193 | ||
| 20-Day SMA ($) | 1.13279 | ||
| 12-1 Month Momentum % | -92.19 | ||
| 52-Week Range ($) | 0.48 - 12.76 | ||
| Shares Outstanding (Mil) | 26.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
23andMe Holding Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
23andMe Holding Co Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
23andMe Holding Co Frequently Asked Questions
What is 23andMe Holding Co(MEHCQ)'s stock price today?
The current price of MEHCQ is $1.40. The 52 week high of MEHCQ is $12.76 and 52 week low is $0.48.
When is next earnings date of 23andMe Holding Co(MEHCQ)?
The next earnings date of 23andMe Holding Co(MEHCQ) is 2025-05-23 Est..
Does 23andMe Holding Co(MEHCQ) pay dividends? If so, how much?
23andMe Holding Co(MEHCQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers